Genpact (NYSE:G) is a global professional services firm that focuses on digital transformation and business process management. The company provides services to various industries, including banking, insurance, and healthcare. Genpact competes with other major players in the industry, such as Accenture and IBM, offering innovative solutions to enhance business operations.
On December 12, 2025, Susquehanna set a price target of $50 for Genpact, while the stock was trading at $47.24. This target suggests a potential increase of approximately 5.84%. Susquehanna initiated coverage with a Neutral view, as reported by TheFly. This indicates a cautious stance, reflecting the stock's current market conditions.
Zacks Investment Research highlights Genpact as a top growth stock for long-term investment. The company is recognized for its potential to outperform the market, supported by favorable ratings in the Zacks Style Scores. These scores evaluate stocks based on value, growth, and momentum, helping investors identify promising opportunities.
Currently, Genpact's stock is priced at $47.33, showing a slight decrease of 0.07% with a change of $0.035. The stock has fluctuated between $47.14 and $47.59 today. Over the past year, it has reached a high of $56.76 and a low of $37.49, indicating some volatility in its performance.
Genpact has a market capitalization of approximately $8.28 billion, reflecting its significant presence in the industry. The trading volume for the day is 342,606 shares on the NYSE, suggesting active investor interest. This data supports the view that Genpact remains a strong contender in the market, with potential for future growth.
